Park, Sang Geun,Shin, Hye Gyeong,Bae, Jeong Woo,Choi, Hyun Ju
申请号：
AU2016255302
公开号：
AU2016255302A1
申请日:
2016.04.27
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to a rivastigmine-containing sustained-release pharmaceutical composition and, more specifically, to a rivastigmine-containing sustained-release pharmaceutical composition, which is a sustained-release preparation containing a pH-dependent delayed release phase, wherein, by controlling the release of the pharmaceutical composition to be minimized in the stomach at the initial stage of administration, the pharmaceutical composition can lower the maximum blood concentration (C
